ICAD
ICAD Inc
Price:  
1.28 
USD
Volume:  
53,047.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICAD EV/EBITDA

-228.7%
Upside

As of 2024-07-27, the EV/EBITDA ratio of ICAD Inc (ICAD) is -2.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICAD's latest enterprise value is 13.69 mil USD. ICAD's TTM EBITDA according to its financial statements is -4.69 mil USD. Dividing these 2 quantities gives us the above ICAD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 4.3x - 17.7x 11.0x
Forward P/E multiples 9.8x - 21.3x 16.4x
Fair Price (0.97) - (2.36) (1.65)
Upside -176.1% - -284.7% -228.7%
1.28 USD
Stock Price
(1.65) USD
Fair Price

ICAD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-26 -2.92
2024-07-25 -3.14
2024-07-24 -3.03
2024-07-23 -3.20
2024-07-22 -3.14
2024-07-19 -3.03
2024-07-18 -3.37
2024-07-17 -3.43
2024-07-16 -3.43
2024-07-15 -2.75
2024-07-12 -3.03
2024-07-11 -2.97
2024-07-10 -3.03
2024-07-09 -2.81
2024-07-08 -2.64
2024-07-05 -2.47
2024-07-03 -2.58
2024-07-02 -2.41
2024-07-01 -2.83
2024-06-28 -3.03
2024-06-27 -3.03
2024-06-26 -2.92
2024-06-25 -2.97
2024-06-24 -3.09
2024-06-21 -3.71
2024-06-20 -3.88
2024-06-18 -3.88
2024-06-17 -4.11
2024-06-14 -4.28
2024-06-13 -4.45
2024-06-12 -4.39
2024-06-11 -4.33
2024-06-10 -4.33
2024-06-07 -4.22
2024-06-06 -4.39
2024-06-05 -4.39
2024-06-04 -4.50
2024-06-03 -4.96
2024-05-31 -3.88
2024-05-30 -4.19
2024-05-29 -4.28
2024-05-28 -4.33
2024-05-24 -4.62
2024-05-23 -4.79
2024-05-22 -4.73
2024-05-21 -4.90
2024-05-20 -4.96
2024-05-17 -5.58
2024-05-16 -5.69
2024-05-15 -4.90